Metrics as of 10/16/2026, 12:58 PM (Berlin time), refresh in progress.
Humana Stock
Humana Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Country
- United States
- CEO
- James A. Rechtin
- Employees
- 67,060
- Market cap
- $51.9 B
- IPO
- 31/12/1981
Humana Inc. is a major player in the U.S. healthcare sector, offering a wide range of medical insurance services and specialized healthcare services. Headquartered in Louisville, Kentucky, the company organizes its operations into the Retail, Group and Specialty, and Healthcare Services segments. Beyond its core…
AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.
Humana stock: price history
1D
+1.1%
1W
+11.6%
1M
+9.0%
6M
+115.3%
YTD
+68.7%
1Y
+64.9%
2Y
+67.8%
5Y
-2.0%
10Y
+153.0%
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~22% stronger price swings than usual
Humana stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Humana Inc. is a U.S.-based healthcare company that distributes its business operations across two main segments: insurance services and direct health services. The company offers health insurance for individuals, group customers, and government programs, such as administering Medicare and Medicaid benefits on behalf of the Centers for Medicare and Medicaid Services. Beyond insurance, Humana provides specialized services in pharmacy management and offers home care solutions as well as network services for healthcare providers. With a customer base of over 20 million insureds and participants in specialty products, the company maintains broad market coverage.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- High
- Customer concentration
- Low
Ask the agents about Humana
Analyst assessment of Humana
PRICE TARGET LOW
US$300.00
CONSENSUS
US$469.89
MEDIAN
US$475.00
PRICE TARGET HIGH
US$596.00
0
STRONG BUY
20
BUY
23
HOLD
1
SELL
0
STRONG SELL
44
TOTAL · Hold
As of: 13/10/2026
Humana stock metrics
P/E
40.58
P/B
2.7
EV/EBITDA
19.13
RETURN ON EQUITY
3.6%
NET MARGIN
1.7%
DEBT/EQUITY
0.74
DIVIDEND YIELD
0.8%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.8%
FLOAT SHARES
119,826,939
AVG. DAILY VOLUME (30D)
1,351,667
Insider transactions (SEC)
Nundy Shantanu
Crawford Frederick John
Smith Paul John
Shetty Sanjay K
Rechtin James A.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +1.1%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Humana stock
What does Humana do?
Humana Inc. is a company in the Healthcare sector, Medical - Healthcare Plans industry, headquartered in United States.
The CEO is James A. Rechtin, the company employs around 67,060 people.
The IPO was on 31/12/1981; the stock trades on NYSE under the ticker HUM.
What do analysts say about Humana stock?
44 analysts rate the stock, the consensus is Hold (as of 13/10/2026).
The average price target is US$469.89, ranging from US$300.00 to US$596.00, with a median of US$475.00.
This is an external assessment, not a statement by Market Jury.
When does Humana report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly 22% stronger than usual.
Does Humana pay a dividend?
Yes. The last dividend was US$0.89 per share, ex-date 30/10/2026, paid on 27/11/2026.
The dividend yield is 0.8% (as of 30/06/2026).
Which stocks are comparable to Humana?
Comparable stocks include UnitedHealth Group, CVS Health, Elevance Health, Cigna, Centene, Molina Healthcare and Oscar Health.
How can I get Humana stock analyzed?
Clicking "Analyze stock" lets five strategies assess Humana against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.